China Cycle 2023: CST debuts CST COREX two-wheeled tire product, promotes sustainable development for ESG project globally

SHANGHAI, May 7, 2023 /PRNewswire/ — Cheng shin Rubber (Xiamen) IND., LTD. (“CST”), a leading manufacturer of two-wheeled tires, has launched CST COREX, an innovative product built with ECO-RE technology at the 31st China International Bicycle Fair (China Cycle 2023). Themed “Safer,…

Salem State University launches the largest fundraising campaign in Massachusetts state university history

SALEM, Mass., May 6, 2023 /PRNewswire/ — On May 6, 2023, Salem State University announced the public launch of a $75 million fundraising campaign, the largest philanthropic endeavor in the history of Massachusetts’ nine state universities. The Meet the Moment™ campaign combines deep…

BLOCK SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Block To Contact Him Directly To Discuss Their Options

NEW YORK, May 6, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Block, Inc. f/k/a Square, Inc. (“Block” or the “Company”) (NYSE: SQ). If you suffered losses exceeding $50,000 investing in Block stock or options…

Creality Shows an Array of Hyper-speed 3D Printers at RAPID+TCT 2023

SHENZHEN, China, May 6, 2023 /PRNewswire/ — Creality brings a striking line-up of high-speed 3D printer flagships to Chicago’s McCormick Place from May 2 to 4 for RAPID + TCT 2023, the largest and most influential additive manufacturing (AM) event in North America. Among the dazzling…

SuzhouGenAssist Therapeutic Co.,Ltd recently announced that its first base editing product, GEN6050, has submitted a pre-IND application to the FDA and has been accepted

SUZHOU, China, May 6, 2023 /PRNewswire/ — Suzhou GenAssist Therapeutic Co.,Ltd recently announced its pre-IND application of their first base editing product, GEN6050 and the acceptance by the FDA. GEN6050 is an in vivo base editing drug that targets exon 50 skipping in the Duchenne…

RITE AID SHAREHOLDER NOTICE : Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Rite Aid To Contact Him Directly To Discuss Their Options

NEW YORK, May 6, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Rite Aid Corporation (“Rite Aid” or the “Company”) (NYSE: RAD) and reminds investors of the May 19, 2023 deadline to seek the role of lead…

Le BYM600 de BENY améliore l’extraction d’énergie en Pologne

WENZHOU, Chine, 5 mai 2023 /PRNewswire/ — China-BENY, un fournisseur mondial de solutions d’énergie renouvelable, a annoncé qu’il présentera son système de micro-onduleur solaire de balcon en Pologne pour la première fois lors du salon Green Power du 16 au 18 mai (stand no 5 du pavillon…

Parks Associates: Smart Watch Adoption Jumps from 30% in 2022 to 35% in 2023

Parks Associates addresses health and home technologies at Connected Health Summit DALLAS, May 5, 2023 /PRNewswire/ — Parks Associates’ latest research shows 56% of US internet households now own a connected health device, a 21-point increase since 2016, with smart watch adoption…

An Overwhelming Majority of 81% Organizations are Experiencing a Shortage in Skilled Tech Workers: EY and iMocha report

28% of organizations believe that they would need to revamp tech skills for a third of their talent base by 2025 to stay competitive Merely 19% organizations have established a skill taxonomy BANGALORE, India, May 5, 2023 /PRNewswire/ — EY, the leading professional services organization…

KISS Products, Inc Launches Out-Of-Home Advertising in NYC & Los Angeles to Support NEW Lash Game Changer: imPRESS Falsies

NEW YORK, May 5, 2023 /PRNewswire/ — KISS Products, Inc. is excited to announce it will be launching a disruptive out-of-home advertising campaign in NYC & Los Angeles to support its latest innovation, imPRESS Falsies. Since its launch earlier this year, imPRESS Falsies has taken…

« Previous Page — Next Page »